New Stent Created With Rutgers Technology in Clinical Trials
A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers, The State University of New Jersey, has been implanted in patients for the first time.
A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers, The State University of New Jersey, has been implanted in patients for the first time.
Could it be that when Ludwig van Beethoven composed some of the greatest masterpieces of all time that he was quite literally following his heart?
As many as 500,000 people in the US have a heritable and potentially fatal heart disease called hypertrophic cardiomyopathy. The disease can cause irregular heartbeats, heart valve problems, heart failure, and, in rare cases, sudden cardiac death in young people.
Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania.
For years, a multidisciplinary team of Johns Hopkins researchers has tracked an elusive creature, a complex of proteins thought to be at fault in some cases of sudden cardiac death.
Mount Sinai Hospital’s Cardiologists Contribute to the Creation of Newly Proposed MOGE(S) Classification System for Cardiomyopathy Disorders, with an Easy-to-Use Online Diagnostic App for Physicians
Leading cardiologists at The Mount Sinai Hospital have contributed to the development of a new classification system called MOGE(S) for cardiomyopathies, the diseases of the heart muscle which can lead to heart enlargement and heart failure.